130
Views
14
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for the treatment of metastatic renal cancer

, MD & , MD
Pages 605-618 | Published online: 05 Nov 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Georgios Pantouris, James Loudon-Griffiths & Christopher G. Mowat. (2016) Insights into the mechanism of inhibition of tryptophan 2,3-dioxygenase by isatin derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry 31:sup1, pages 70-78.
Read now
Angiolo Gadducci, Roberta Tana, Stefania Cosio, Antonio Fanucchi & Andrea Riccardo Genazzani. (2008) Molecular target therapies in endometrial cancer: From the basic research to the clinic. Gynecological Endocrinology 24:5, pages 239-249.
Read now

Articles from other publishers (12)

Shaojuan Hu & Timon Cheng‐Yi Liu. (2023) Mechanism of action of photobiomodulation with light‐emitting diode on the glutamine‐dependent CT26 cell . Journal of Biophotonics.
Crossref
Walaa Abdelhamed & Mohamed El-Kassas. (2022) Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event. World Journal of Gastrointestinal Oncology 14:6, pages 1103-1114.
Crossref
Woubet Tefera Kassahun. (2016) Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments. World Journal of Surgical Oncology 14:1.
Crossref
A. P. Trashkov, N. A. Verlov, N. V. Tsygan, M. R. Artemenko, V. A. Pechatnikova, A. G. Vasiliev, R. V. Korablev & T. A. Verlova. (2015) Neoangiogenesis control in oncology: mechanisms and prospects of practical application. Regional blood circulation and microcirculation 14:4, pages 11-17.
Crossref
Ramon Salazar, Diane Reidy-Lagunes & James Yao. (2011) Potential Synergies for Combined Targeted Therapy in the Treatment of Neuroendocrine Cancer. Drugs 71:7, pages 841-852.
Crossref
Bryan Y. Wong & Wolfram E. Samlowski. 2010. Medical Therapy in Urology. Medical Therapy in Urology 17 31 .
RuiRong Yuan, Andrea Kay, William J Berg & David Lebwohl. (2009) Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy. Journal of Hematology & Oncology 2:1.
Crossref
Jessie Villanueva & Meenhard Herlyn. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Bernard Escudier & John A. Thompson. (2009) Mechanism of action of everolimus in renal cell carcinoma. Medical Oncology 26:S1, pages 32-39.
Crossref
Wolfram E. Samlowski & Nicholas J. Vogelzang. (2008) Conclusion and Future Directions. The Cancer Journal 14:5, pages 330-332.
Crossref
Wolfram E. Samlowski, Bryan Wong & Nicholas J. Vogelzang. (2008) Management of renal cancer in the tyrosine kinase inhibitor era: a view from 3 years on. BJU International 102:2, pages 162-165.
Crossref
Shridhar Hegde & Michelle Schmidt. 2008. 455 497 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.